Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical challenges, and ...
FDA expects to issue guidance on policies regarding generative AI devices, according to Rick Abramson, the agency’s head of ...
The Food and Drug Administration has again paused trials for Regenxbio’s gene therapy for a rare childhood brain disorder, ...
This story about nurse practitioners was produced by The Hechinger Report, a nonprofit, independent news organization focused ...
New clues to RFK Jr.'s vaccine plans, a bottleneck for nurse practitioners, and more health news from Morning Rounds ...
The Trump administration plans to use a new approach to deny Medicaid coverage of drugs for gender-affirming care. The ...
Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is not ...
FTC challenges Amgen's Enbrel patent strategy, the long, winding path for the Moderna-Merck cancer vaccine, and more biotech ...
Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. WASHINGTON — ...
New restrictions on the use of food benefits to purchase soda and candy have been one of the biggest changes enacted by the Make America Healthy Again movement. But a key question has been how ...
Isabella is a chronic disease reporter writing about how the Trump administration is tackling the nation’s health epidemic — or not. You can reach her on Signal at isabellacueto.03. The American ...
Politicians are contemplating raising taxes and cutting benefits as the cost of health care for government workers surges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results